No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide

Amid the global shortage of Lupron, used to treat pain associated with cancer, AbbVie took its partner Takeda to court over alleged failures to live up to supply agreements. Now, a court has denied the company's plea to force Takeda to fill orders.

In an opinion this week, Delaware Chancery Court Vice Chancellor Sam Glasscock III denied AbbVie's request to compel Takeda to fill supply orders from its plant in Hikari, Japan.